Announcement by Zhongzheng Pengyuan on the Resignation of Directors at Hainan Puli Pharmaceutical Co., Ltd. and Inability to Disclose Periodic Reports on Time
Zhongzheng Pengyuan Credit Rating Co., Ltd. (hereinafter referred to as "Zhongzheng Pengyuan") has conducted ratings for Hainan Puli Pharmaceutical Co., Ltd. (hereinafter referred to as "Puli Pharmaceutical" or "the Company", stock code: 300630.SZ) and the bonds issued by it. Apart from the rating commission relationship, Zhongzheng Pengyuan and its rating personnel have no relationships that could affect the independence, objectivity, and fairness of the rating.
| Bond Name | Last Rating Date | Last Rating Result | Entity Rating | Bond Rating | Rating Outlook |
|---|---|---|---|---|---|
| Puli Convertible Bond | April 25, 2025 | B+ | B+ | Negative |